BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10934954)

  • 1. Reproducibility in double scanning of cervical smears with the PAPNET system.
    Doornewaard H; van der Schouw YT; van der Graaf Y
    Acta Cytol; 2000; 44(4):604-10. PubMed ID: 10934954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the cervical cytology test using the PAPNET method and conventional microscopy.
    Weissbrod D; Torres M; Rodríguez A; Ureña I; Estrada J; Reyes ME; Carreto AJ
    Bull Pan Am Health Organ; 1996 Dec; 30(4):339-47. PubMed ID: 9041745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of unsuspected abnormalities by PAPNET-assisted review.
    Mitchell H; Medley G
    Acta Cytol; 1998; 42(1):260-4. PubMed ID: 9479349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
    Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
    Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An interlaboratory study of the use of PapNet in the quality control of cervico-vaginal cytology].
    Cosentino A; Ghidoni D; Salemi M; Folicaldi S; Amadori A; Zani J; Grasso G; Bondi A
    Pathologica; 1999 Apr; 91(2):101-6. PubMed ID: 10484869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAPNET computer-aided rescreening for detection of benign and malignant glandular elements in cervicovaginal smears: a review of 61 cases.
    Sturgis CD; Isoe C; McNeal NE; Yu GH; DeFrias DV
    Diagn Cytopathol; 1998 Apr; 18(4):307-11. PubMed ID: 9557269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consistency of a double PAPNET scan of cervical smears.
    Jenny J; Isenegger I; Boon ME; Husain OA
    Acta Cytol; 1997; 41(1):82-7. PubMed ID: 9022731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of laboratory false negative smears by the PAPNET cytologic screening system.
    Mitchell H; Medley G
    Acta Cytol; 1998; 42(1):265-70. PubMed ID: 9479350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PAPNET system for quality control of cervical smears: validation and limits.
    Cenci M; Nagar C; Giovagnoli MR; Vecchione A
    Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between false-negative and true-positive Papanicolaou smears on Papnet-assisted review.
    Mitchell H; Medley G
    Diagn Cytopathol; 1998 Aug; 19(2):138-40. PubMed ID: 9702494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
    Sherman ME; Schiffman M; Herrero R; Kelly D; Bratti C; Mango LJ; Alfaro M; Hutchinson ML; Mena F; Hildesheim A; Morales J; Greenberg MD; Balmaceda I; Lorincz AT
    Cancer; 1998 Oct; 84(5):273-80. PubMed ID: 9801201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL; Acosta D; Peters RK
    Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. PRISMATIC Project Management Team.
    Lancet; 1999 Apr; 353(9162):1381-5. PubMed ID: 10227217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality control of cervical cytology in high-risk women. PAPNET system compared with manual rescreening.
    Bergeron C; Masseroli M; Ghezi A; Lemarie A; Mango L; Koss LG
    Acta Cytol; 2000; 44(2):151-7. PubMed ID: 10740599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Papnet-assisted and manual screening of cervical smears.
    Losell K; Dejmek A
    Diagn Cytopathol; 1999 Oct; 21(4):296-9. PubMed ID: 10495327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost analysis of PAPNET-assisted vs. conventional Pap smear evaluation in primary screening of cervical smears.
    Meerding WJ; Doornewaard H; van Ballegooijen M; Bos A; van der Graaf Y; van den Tweel JG; van der Schouw YT; Habbema JD
    Acta Cytol; 2001; 45(1):28-35. PubMed ID: 11213501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAPNET for analysis of proliferating (MIB-1 positive) cell populations in cervical smears.
    Boon ME; Kleinschmidt-Guy ED; Ouwerkerk-Noordam E
    Eur J Morphol; 1994 Mar; 32(1):78-85. PubMed ID: 8086271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of endocervical component by PAPNET system on negative cervical smears.
    Ashfaq R; Solares B; Saboorian MH
    Diagn Cytopathol; 1996 Aug; 15(2):121-3. PubMed ID: 8872433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.